Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Sep-24 4:30 PM View:  | Dunn Gordon Chief Financial Officer | Quoin Pharmaceuticals, Ltd. (QNRX) | 10-Sep-24 | Purchase | 20,000 | $0.81 | $16,200.00 | 226% 8.86K to 28.86K | |
| 11-Sep-24 4:30 PM View: | Dunn Gordon Chief Financial Officer | Quoin Pharmaceuticals, Ltd. (QNRX) | 09-Sep-24 | Purchase | 8,856 | $0.79 | $7,004.80 | 100% 0 to 8.86K | |
| 05-Sep-24 12:06 PM View: | Carter Denise P. Chief Operating Officer Director | Quoin Pharmaceuticals, Ltd. (QNRX) | 04-Sep-24 | Purchase | 31,813 | $0.78 | $24,911.90 | 208% 15.28K to 47.09K | |
| 05-Sep-24 12:03 PM View: | Myers Michael Chief Executive Officer Director | Quoin Pharmaceuticals, Ltd. (QNRX) | 04-Sep-24 | Purchase | 37,094 | $0.77 | $28,420.90 | 365% 10.16K to 47.25K | |
| 05-Sep-24 12:03 PM View: | Myers Michael Chief Executive Officer Director | Quoin Pharmaceuticals, Ltd. (QNRX) | 03-Sep-24 | Purchase | 800 | $0.62 | $495.20 | 9% 9.36K to 10.16K | |
| 05-Sep-24 12:06 PM View: | Carter Denise P. Chief Operating Officer Director | Quoin Pharmaceuticals, Ltd. (QNRX) | 03-Sep-24 | Purchase | 5,922 | $0.65 | $3,825.21 | 63% 9.36K to 15.28K | |
| 10-Jun-24 4:10 PM View: | Langer Dennis Director | Quoin Pharmaceuticals, Ltd. (QNRX) | 07-Jun-24 | Private Sale | 297 | $0.73 | $217.40 | (85%) 0.35K to 53 |
